GlassScriptPhysician profile
Rajiv Datta
NPI 1457347601
$4,355.08
in general payments reported to CMS, 2019-2025
21 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $21.33 · 2021: $94.39 · 2022: $1,723 · 2023: $776 · 2024: $259 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,667.71 | 2022-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $637.91 | 2021-2025 | Signia, Signet, Ligasure |
| Baxter Healthcare | $568.42 | 2019 | |
| Covidien LP | $272.09 | 2019 | |
| Hologic Sales and Service, LLC | $177.65 | 2023-2024 | Trident Specimen Radiography System, Localizer, Trunode |
| Allergan, INC. | $144.45 | 2019 | |
| Tactile Systems Technology INC | $130.81 | 2023 | Flexitouch Plus, Entre Plus |
| Glaxosmithkline, LLC. | $124.76 | 2023 | Shingrix |
| Ethicon US, LLC | $116.66 | 2019-2025 | Evarrest, Stratafix, Surgiflo Hemostatic Matrix |
| Avanos Medical | $115.28 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $76.55 | 2019-2024 | Caldolor |
| Inspire Medical Systems, INC. | $73.21 | 2024 | Inspire |
| Stryker Corporation | $48.67 | 2023 | Spy-Phi System |
| Polynovo North America LLC | $41.95 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $35.00 | 2023-2024 | Xarelto |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $27.32 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Bioventus LLC | $22.25 | 2023 | Theragenesis Bilayer Wound Matrix |
| Kci USA, INC. | $21.33 | 2020 | |
| Lupin INC. | $20.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.29 | 2024 | Gattex |
| Thd America, INC. | $14.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Datta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.